L'intérêt à découvert pour FMC donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de FMC. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

FMC (NYSE:FMC) Stock, Rapport sur les intérêts à découvert

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

FMC Corp

FRMRS&MER BNCORP LODI CA by Farmers & Merchants Bancorp

Farmers & Merchants Bancorp

Federal Home Loan Mortgage Corp

FRESENIUS MED CARE AG ORD by Fresenius Medical Care AG

Fresenius Medical Care AG

FRESENIUS MEDICAL CARE ORD

FM Focus Equity ETF

FORAN MINING CORP by Foran Mining Corporation

Foran Mining Corp

FMC Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) stock looks promising at the moment. It benefits from efforts to expand its product portfolio through new product launches and its restructuring actions.
Let&#39;s see what makes FMC stock a compelling investment option at the moment.
<h2>FMC Stock Outperforms Industry</h2>
FMC has outperformed the industry it belongs to over the past three months. The company&#39;s shares have gained 13.8% compared with a 7.7% rise of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/c7/80480.jpg?v=1918707670" />
Image Source: Zacks Investment Research
<h2>FMC&#39;s Valuation Looks Attractive</h2>
FMC&#39;s attractive valuation should lure investors seeking value. The stock is currently trading at a forward 12-month earnings multiple of 14.52X, representing a roughly 12.4% discount when stacked up with the industry average of 16.58X. FMC also has a Value Score of B.
<h2>FMC&#39;s Earnings Estimates Going Up</h2>
Earnings estimates for FMC have been going up over the past 60 days. The Zacks Consensus Estimate for 2024 has increased by 0.6%. The consensus estimate for 2025 has also been revised 3.5% upward over the same time frame.
<h2>New Products, Restructuring Actions Aid FMC Stock</h2>
FMC remains focused on strengthening its product portfolio. It is investing in technologies as well as new product launches to enhance value to the farmers. New products launched in Europe, North America and Asia are gaining significant traction. Product introductions are expected to support the company&#39;s results this year.
FMC generated $590 million in sales in 2023 from new products launched in the past five years. It expects revenues from new products to grow by roughly $200 million in 2024. It expects a significant amount of volume growth to come from new products in the second half of 2024. FMC is seeing strong gains in new products including Coragen eVo and Premio Star insecticides and the Onsuva fungicide in Latin America.
The acquisition of BioPhero ApS, a Denmark-based pheromone research and production company, also adds biologically produced state-of-the-art pheromone insect control technology to the company&#39;s product portfolio and R&amp;D pipeline, highlighting FMC&#39;s role as a leader in delivering innovative and sustainable crop protection solutions.
The company is also expected to benefit from reduced input costs, favorable product mix and its cost-control actions. It benefited from favorable input costs in the second quarter of 2024. FMC is also making progress with its global restructuring and cost-reduction program. It sees benefits from restructuring to contribute $75-$100 million to full-year 2024 adjusted EBITDA, net of inflation.
<div class="chart_embed">
<h3>FMC Corporation Price and Consensus</h3>
<img alt="FMC Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/17/1728291628.png" style="height:265px; width:576px" title="" />
FMC Corporation price-consensus-chart | FMC Corporation Quote
</div>
<h2>FMC&#39;s Zacks Rank &amp; Other Key Picks</h2>
FMC currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks in the Basic Materials space are IAMGOLD Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iag#NYSE">IAG</a>), Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>) and Axalta Coating Systems Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>). While IAMGOLD sports a Zacks Rank #1 (Strong Buy), Cabot and Axalta Coating carry a Zacks Rank #2.
The Zacks Consensus Estimate for IAMGOLD&#39;s current-year earnings has increased by 45.4% in the past 60 days. IAG beat the consensus estimate in each of the last four quarters with the average surprise being 200%. Its shares have shot up roughly 132% in the past year.
The consensus estimate for Cabot&#39;s current fiscal year earnings is pegged at $7.07 per share, indicating a year-over-year rise of 31.4%. The consensus estimates for CBT&#39;s current-year earnings has increased by 4.3% in the past 60 days. The company&#39;s shares have rallied roughly 61% in the past year.
The Zacks Consensus Estimate for Axalta Coating&#39;s current year earnings is pegged at $2.07, indicating a rise of 31.9% from year-ago levels. The Zacks Consensus Estimate for AXTA&#39;s current year earnings has increased 2.5% in the past 60 days. The stock has gained around 32% in the past year.
<a href="https://www.zacks.com/stock/news/2346902/here-s-why-you-should-add-fmc-stock-to-your-portfolio-now?cid=CS-BENZ-FT-analyst_blog|rank_focused-2346902">To read this article on Zacks.com click here.</a>

Earnings

Earnings Beats

Mid Cap

News

Penny Stocks

Markets

Analyst Ratings

Trading Ideas

AXTA

Here's Why You Should Add FMC Stock to Your Portfolio Now

FMC Signs Distribution Agreement With Ballagro Agro Tecnologia To Expand Biological Crop Protection Solutions In Brazil, Strengthening Biosolutions Offering In Key Market

FMC Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) shares have gained 9.6% over the past three months. The company has also outperformed its industry&#39;s decline of 7.8% over the same time frame. FMC has also topped the S&amp;P 500&#39;s roughly 2.9% rise over the same period.
Let&#39;s dive into the factors behind this Zacks Rank #3 (Hold) stock&#39;s price appreciation.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/25/76914.jpg?v=1710638083" style="height:412px; width:610px" />
Image Source: Zacks Investment Research
<h2>New Products, Restructuring Actions Aid FMC Stock</h2>
FMC delivered better-than-expected results in the second quarter on the back of higher volumes. It saw improved demand in the quarter, leading to an increase in sales volumes, especially in the United States and Brazil. The company is gaining from efforts to expand its product portfolio through new product launches and restructuring actions.
FMC is investing in technologies as well as new product launches to enhance value to the farmers. New products launched in Europe, North America and Asia are gaining significant traction. Product introductions are expected to support the company&#39;s results this year.
The company generated $590 million in sales in 2023 from new products launched in the past five years. It expects revenues from new products to grow by roughly $200 million in 2024. It expects a significant amount of volume growth to come from new products in the second half of 2024. FMC is seeing strong gains in new products including Coragen eVo and Premio Star insecticides and the Onsuva fungicide in Latin America.
The acquisition of BioPhero ApS, a Denmark-based pheromone research and production company, also adds biologically produced state-of-the-art pheromone insect control technology to the company&#39;s product portfolio and R&amp;D pipeline, highlighting FMC&#39;s role as a leader in delivering innovative and sustainable crop protection solutions.
FMC is also expected to benefit from reduced input costs, a favorable product mix and its cost-control actions. It benefited from favorable input costs in the second quarter of 2024. FMC is also making progress with its global restructuring and cost-reduction program. It sees benefits from restructuring to contribute $75-$100 million to full-year 2024 adjusted EBITDA, net of inflation.
<div class="chart_embed">
<h3>FMC Corporation Price and Consensus</h3>
<img alt="FMC Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/18/1725873589.png" style="height:265px; width:576px" title="" />
FMC Corporation price-consensus-chart | FMC Corporation Quote
</div>
<h2>Stocks to Consider</h2>
Better-ranked stocks in the Basic Materials space are Newmont Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nem#NYSE">NEM</a>), Element Solutions Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/esi#NYSE">ESI</a>) and Eldorado Gold Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ego#NYSE">EGO</a>), each sporting a Zacks Rank #1 (Strong Buy).
The Zacks Consensus Estimate for Newmont&#39;s current-year earnings is pegged at $2.82, indicating a rise of 75.2% from year-ago levels. The Zacks Consensus Estimate for NEM&#39;s earnings has increased 16% in the past 60 days. The stock has rallied around 29% in the past year.
The consensus estimate for Element Solutions&#39; current-year earnings has increased by 0.7% in the past 60 days. ESI beat the consensus estimate in three of the last four quarters while delivering in-line results on the other occasion. In this timeframe, it delivered an earnings surprise of around 3.8%, on average.
The Zacks Consensus Estimate for Eldorado Gold&#39;s current year earnings is pegged at $1.35 per share, indicating a year-over-year rise of 136.8%. EGO beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 430.3%. The company&#39;s shares have rallied roughly 61% in the past year.
<a href="https://www.zacks.com/stock/news/2333348/fmc-shares-rise-10-in-3-months-what-s-driving-the-stock?cid=CS-BENZ-FT-analyst_blog|price_surge_/_plunge-2333348">To read this article on Zacks.com click here.</a>

Large Cap

FMC Shares Rise 10% in 3 Months: What's Driving the Stock?

Legal

FMC Corporation Granted Temporary Restraining Order Against Sharda US, Which Restrains Sharda From Importing, Marketing, Advertising, Selling Or Distributing Any Premix Products Containing Bifenthrin And Cyano-Pyrethroids That Are Covered By FMC's Patents

FMC Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) recently filed regulatory applications for the Dodhylex active herbicide in eight rice-growing countries. Registration dossiers were submitted in India, Brazil, the Philippines, the United States, Colombia, South Korea, Peru and Taiwan, accounting for roughly 35% of the estimated 165 million hectares of planted rice worldwide. Dodhylex active regulatory filings are planned for a number of other significant global markets.
The Herbicide Resistance Action Committee and the Weed Science Society of America have categorized Dodhylex active, FMC&#39;s brand name, as tetflupyrolimet, which is a Group 28 herbicide, thereby making it the first novel mode of action herbicide globally in more than three decades. Dodhylex active will be a significant new rotational tool for farmers to manage herbicide resistance, which is becoming an increasingly difficult concern for growers around the world.
Dodhylex active is a key improvement for the agriculture industry because it combats resistant grass weeds. According to studies, this proprietary molecule provides season-long control of resistant grass weeds in rice, irrespective of cultivation method. FMC is continuing to evaluate the application of Dodhylex active in other crops such as sugarcane, wheat, soybeans and corn.
FMC&#39;s innovation and methodical approach to develop novel molecules to facilitate food security for an expanding population and fight resistance are demonstrated by the discovery and development of Dodhylex active at the Stine Research Centre. Subject to regulatory decisions, FMC expects the first launches of Dodhylex in 2026.
Shares of FMC have lost 28.5% over the past year compared with its industry&#39;s 6.5% decline.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/ed/74850.jpg?v=386357879" />
Image Source: Zacks Investment Research
FMC, on its second-quarter call, updated its revenue outlook for full-year 2024 and now expects revenues to be between $4.30 billion and $4.50 billion, indicating a 2% decline at the midpoint from 2023. Adjusted EBITDA is now expected to be in the range of $880- $940 million, indicating a 7% decline at the midpoint from the prior year. Adjusted earnings per share are now forecast to be between $3.02 and $3.64, implying a 12% year-over-year decline at the midpoint. Full-year free cash flow is anticipated to be in the band of $400-$500 million.
FMC also forecasts third-quarter revenues to be between $1 billion and $1.09 billion, indicating a 6% increase at the midpoint from the third quarter of 2023. Adjusted EBITDA is forecast to be in the band of $165-$195 million, indicating a 3% rise from the prior-year level. Adjusted earnings per share are expected to be in the range of 39-67 cents, indicating a 20% rise at the midpoint from the third-quarter 2023 level.
<div class="chart_embed">
<h3>FMC Corporation Price and Consensus</h3>
<h3><img alt="FMC Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/d5/1724238098.png" style="height:265px; width:577px" title="" /></h3>
FMC Corporation price-consensus-chart | FMC Corporation Quote
</div>
<h3>Zacks Rank &amp; Key Picks</h3>
FMC currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks in the basic materials space are Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>), Eldorado Gold Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ego#NYSE">EGO</a>) and Agnico Eagle Mines Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aem#NYSE">AEM</a>).
CRS beat the Zacks Consensus Estimate in the last four quarters, with the average earnings surprise being 15.9%. The company&#39;s shares have gained 154.7% in the past year.&nbsp; Carpenter Technology currently sports a Zacks Rank #1 (Strong Buy).
The Zacks Consensus Estimate for Eldorado&#39;s current-year earnings is pegged at $1.32 per share, indicating a year-over-year rise of 131.6%. The consensus estimate for EGO&#39;s current-year earnings has gone up in the past 30 days.
EGO, which currently sports a Zacks Rank of 1, beat the consensus estimate in the last four quarters, with the average earnings surprise being 430.3%. The company&#39;s shares have gained roughly 107.3% in the past year.
Agnico Eagle Mines currently carries a Zacks Rank #2 (Buy). AEM beat the Zacks Consensus Estimate in the last four quarters, with the average earnings surprise being 15.7%. The company&#39;s shares have gained 73.5% in the past year.
<a href="https://www.zacks.com/stock/news/2324887/fmc-submits-regulatory-applications-for-dodhylex-active?cid=CS-BENZ-FT-analyst_blog|company_news_corporate_actions-2324887">To read this article on Zacks.com click here.</a>

Regulations

FMC Submits Regulatory Applications for Dodhylex Active

Ratings for FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $65.33, a high estimate of $79.00, and a low estimate of $59.00. Surpassing the previous average price target of $64.20, the current average has increased by 1.76%.
<img src="https://www.benzinga.com/files/images/story/2024/1723478441_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of FMC among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$59.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$65.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Joel Jackson</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$65.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$79.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Richard Garchitorena</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$62.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$62.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of FMC's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of FMC's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on FMC analyst ratings.</a>
<h2>All You Need to Know About FMC</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>FMC: Delving into Financials</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining FMC's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 2.36% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Net Margin: FMC's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 28.33%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 6.63%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): FMC's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.44%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 0.92, FMC faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Decoding 6 Analyst Evaluations For FMC

JP Morgan analyst Jeffrey Zekauskas maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral and raises the price target from $50 to $59.

Price Target

JP Morgan Maintains Neutral on FMC, Raises Price Target to $59

Barclays analyst Benjamin Theurer maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Equal-Weight and raises the price target from $62 to $65.

Barclays Maintains Equal-Weight on FMC, Raises Price Target to $65

BMO Capital analyst Joel Jackson maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Market Perform and raises the price target from $60 to $65.

BMO Capital Maintains Market Perform on FMC, Raises Price Target to $65

Keybanc analyst Aleksey Yefremov maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Overweight and lowers the price target from $81 to $79.

Keybanc Maintains Overweight on FMC, Lowers Price Target to $79

U.S. stocks were lower, with the Dow Jones index falling over 500 points on Thursday.
Shares of Air Products and Chemicals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) rose sharply during Thursday's session after the company reported better-than-expected third-quarter <a href="https://www.benzinga.com/news/earnings/24/08/40100921/air-products-q3-win-eps-surge-and-margin-expansion-set-stage-for-promising-q4">adjusted EPS results</a>.
Air Products reported third-quarter 2024 adjusted EPS of $3.20, up 7% year-over-year, beating the consensus of $3.03. Sales declined 2% YoY to $2.986 billion, missing the consensus of $3.035 billion due to 2% unfavorable currency and 1% lower energy cost pass-through.
Air Products shares jumped 11.4% to $293.82 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Lumen Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) shares surged 26.2% to $3.9750. Corning and Lumen reached a supply agreement on next-generation fiber-optic cable to support data center AI demands.</li>
<li>Exact Sciences Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) jumped 24.3% to $56.80 after the company reported better-than-expected second-quarter financial results. Also, the company announced an exclusive license agreement with TwinStrand Biosciences.</li>
<li>Omnicell, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMCL#NASDAQ">OMCL</a>) gained 22.3% to $35.71 after the company reported better-than-expected second-quarter financial results and issued FY24 guidance above estimates.</li>
<li>Shake Shack Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) climbed 17.8% to $103.22 after the company reported better-than-expected second-quarter sales results.</li>
<li>Clearwater Analytics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWAN#NASDAQ">CWAN</a>) gained 17.5% to $22.97 after the company reported better-than-expected second-quarter sales results and issued FY24 revenue guidance above estimates..</li>
<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) jumped 15.8% to $9.12.</li>
<li>C.H. Robinson Worldwide, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) gained 15.1% to $102.48 after the company reported better-than-expected second-quarter adjusted EPS results.</li>
<li>Energy Recovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERII#NASDAQ">ERII</a>) gained 14.7% to $16.72 following upbeat quarterly results.</li>
<li>Frontdoor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTDR#NASDAQ">FTDR</a>) gained 14.2% to $45.06 following better-than-expected second-quarter financial results.</li>
<li>Hawkins, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWKN#NASDAQ">HWKN</a>) rose 14.1% to $118.53 following upbeat quarterly results.</li>
<li>Ranpak Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACK#NASDAQ">PACK</a>) gained 12.7% to $8.14 after the company reported better-than-expected second-quarter EPS results.</li>
<li>Zeta Global Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) rose 12.4% to $24.07 after the company reported better-than-expected quarterly financial results and raised its FY24 revenue guidance above estimates. Additionally, Morgan Stanley and Oppenheimer raised their respective price targets on the stock.</li>
<li>Acadia Healthcare Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) rose 12.2% to $72.73 after the company reported better-than-expected quarterly financial results..</li>
<li>FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) gained 12% to $65.34 following quarterly financial results..</li>
<li>Alnylam Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) rose 10.6% to $262.60 after the company reported better-than-expected quarterly financial results.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) gained 9.5% to $145.82 after the company reported better-than-expected quarterly financial results.</li>
<li>Aptiv PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) gained 5.8% to $73.46 after the company reported better-than-expected second-quarter adjusted EPS results and raised its FY24 adjusted EPS above estimates. Additionally, the company announced the authorization of a $5 billion share repurchase program..</li>
<li>Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) rose 5.8% to $502.20 following better-than-expected quarterly earnings.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40101200/top-3-health-care-stocks-that-are-set-to-fly-this-quarter"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40101200/top-3-health-care-stocks-that-are-set-to-fly-this-quarter">Top 3 Health Care Stocks That Are Set To Fly This Quarter</a></li>
</ul>

Intraday Update

Movers

ACHC

ALNY

APTV

CHRW

CVNA

CWAN

ERII

EXAS

FTDR

HWKN

LUMN

OMCL

PACK

SHAK

ZETA

Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday

WIIM

FMC shares are trading higher following Q2 financial results.

Guidance

FMC Sees FY24 Revenue $4.3B-$4.5B Vs $4.43B Estimate; Sees Adj. EPS $3.02-$3.64 Vs $3.48 Estimate

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.55 by 14.55 percent. The company reported quarterly sales of $1.04 billion which met the analyst consensus estimate. This is a 2.46 percent increase over sales of $1.01 billion the same period last year.

FMC Q2 2024 Adj EPS $0.63 Beats $0.55 Estimate, Sales $1.04B Inline

FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) recently declared a regular quarterly dividend of 58 cents per share, payable on Oct. 17, to shareholders of record as of the close of <a href="https://www.benzinga.com/quote/FMC/dividends">business on Sept. 30</a>.
FMC will release its financial results for the second quarter, after the closing bell on Wednesday.
Analysts expect the Philadelphia, Pennsylvania-based company to report quarterly earnings at 55 cents per share, up from 50 cents per share in the year-ago period. FMC expects to post revenue of $1.04 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
With the recent buzz around FMC, some investors may be eyeing potential gains from the company's dividends. As of now, FMC has a dividend yield of 3.97%, which is a quarterly dividend amount of 58 cents a share ($2.32 a year).
To figure out how to earn $500 monthly from FMC, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by FMC's $2.32 dividend: $6,000 / $2.32 &nbsp;= 2,586 shares
So, an investor would need to own approximately $151,203 worth of FMC, or 2,586 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $2.32 = 517 shares, or $30,229 to generate a monthly dividend income of $100.
Also Read: <a href="https://www.benzinga.com/news/earnings/24/07/40059087/nasdaq-tumbles-amid-decline-in-tech-stocks-greed-index-moves-to-fear-zone">Nasdaq Tumbles As Microsoft, Nvidia And Other Tech Stocks Decline: Greed Index Moves To &#8216;Fear&#8217; Zone</a>
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
FMC Price Action: Shares of FMC fell 1.4% to close at $58.47 on Tuesday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40039797/top-3-health-care-stocks-you-may-want-to-dump-this-quarter">Top 3 Health Care Stocks You May Want To Dump This Quarter</a></li>
</ul>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Image created using artificial intelligence via Midjourney.

Long Ideas

How To Earn $500 A Month From FMC Stock Ahead Of Q2 Earnings

Ratings for FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated FMC and provided 12-month price targets. The average target is $65.86, accompanied by a high estimate of $81.00 and a low estimate of $50.00. This upward trend is evident, with the current average reflecting a 2.63% increase from the previous average price target of $64.17.
<img src="https://www.benzinga.com/files/images/story/2024/1721145644_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of FMC among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Garchitorena</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$62.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$62.00</td>
<td>-</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$81.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$81.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Richard Garchitorena</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$68.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$57.00</td>
<td>$55.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for FMC's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into FMC's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on FMC analyst ratings.</a>
<h2>All You Need to Know About FMC</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>Financial Insights: FMC</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: FMC's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -31.71%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: FMC's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -0.29%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): FMC's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.06% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.02%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 1.01, FMC faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying FMC: Insights From 7 Analyst Reviews

Wells Fargo analyst Richard Garchitorena maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Equal-Weight and lowers the price target from $68 to $62.

Wells Fargo Maintains Equal-Weight on FMC, Lowers Price Target to $62

FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) shares are trading higher today. The company finalized an agreement to sell its Global Specialty Solutions (GSS) business to Environmental Science US, known as Envu, for $350 million, subject to <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/n39740988/fmc-corporation-signs-definitive-agreement-to-sell-global-specialty-solutions-business-to-envu" rel="noreferrer noopener">closing working capital adjustment</a>.
FMC plans to use the proceeds from the sale to reduce debt. The transaction is expected to close by the end of 2024, pending regulatory approval and other customary conditions.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/23/12/36300550/agricultural-science-company-fmcs-project-focus-aims-to-harvest-150m-savings-in-global-restructu" rel="noreferrer noopener">Agricultural Science Company FMC&#8217;s &#8216;Project Focus&#8217; Aims To Harvest ~$150M Savings In Global Restructuring &amp; More</a>.
Marco Strizzi, Senior Principal at Cinven, said, &#8220;We are delighted to bring together two highly respected, complementary businesses with a shared focus on delivering seamless customer service and product innovation in the attractive environmental science market.&#8221;
&#8220;We see FMC GSS as a compelling addition to Envu strategically and financially and look forward to continuing to support the combined business&#8217; strong growth trajectory.&#8221;
Notably, in November 2023, FMC disclosed plans to explore strategic alternatives for its GSS business, which serves diverse non-crop markets such as golf courses, <a target="_blank" href="https://www.benzinga.com/markets/equities/23/11/35849634/agricultural-science-company-fmcs-investor-day-plans-non-core-asset-sale-r-d-pipeline-others" rel="noreferrer noopener">sports stadiums, and pest control.</a>
Last month, FMC&#8217;s Board of Directors appointed Pierre Brondeau as chief executive officer and board chairman. He succeeded Mark Douglas, who stepped down after <a target="_blank" href="https://www.benzinga.com/pressreleases/24/06/n39267559/fmc-corporation-board-of-directors-appoints-pierre-brondeau-chairman-and-chief-executive-officer" rel="noreferrer noopener">more than 14 years with the company</a>.
The company plans to release its second quarter 2024 earnings <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">on July 31, 2024</a>.
Investors can gain exposure to the stock via First Trust Materials AlphaDEX Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXZ#NYSE">FXZ</a>) and Global X AgTech &amp; Food Innovation ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROP#NASDAQ">KROP</a>).
Price Action: FMC shares are up 0.35% at $56.90 premarket at the last check Friday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

Equities

Asset Sales

KROP

FMC Cleans Up Portfolio With GSS Sale, Eyes Debt Reduction and Goes Green

The transaction is expected to close by year-end 2024, subject to regulatory approval and other customary closing conditions. FMC intends to allocate all proceeds from the sale to debt reduction.

Reported Late Thursday, FMC To Divest Global Specialty Solutions Business To Envu In $350M Deal

A smart beta exchange traded fund, the First Trust Materials AlphaDEX ETF (ARCA:FXZ) debuted on 05/08/2007, and offers broad exposure to the Materials ETFs category of the market.
What Are Smart Beta ETFs?
The ETF industry has traditionally been dominated by products based on market capitalization weighted indexes that are designed to represent the market or a particular segment of the market.
Market cap weighted indexes offer a low-cost, convenient, and transparent way of replicating market returns, and are a good option for investors who believe in market efficiency.
However, some investors believe in the possibility of beating the market through exceptional stock selection, and choose a different type of fund that tracks non-cap weighted strategies: smart beta.
Based on specific fundamental characteristics, or a combination of such, these indexes attempt to pick stocks that have a better chance of risk-return performance.
This area offers many different investment choices, such as simplest equal-weighting, fundamental weighting and volatility/momentum based weighting methodologies; however, not all of these strategies can deliver superior results.
Fund Sponsor &amp; Index
The fund is sponsored by First Trust Advisors. It has amassed assets over $371.37 million, making it one of the average sized ETFs in the Materials ETFs. Before fees and expenses, this particular fund seeks to match the performance of the StrataQuant Materials Index.
The StrataQuant Materials Index is a modified equal-dollar weighted index designed by the AMEX to objectively identify and select stocks from the Russell 1000 Index that may generate positive alpha relative to traditional passive style indices through the use of the AlphaDEX screening methodology.
Cost &amp; Other Expenses
For ETF investors, expense ratios are an important factor when considering a fund&#39;s return; in the long-term, cheaper funds actually have the ability to outperform their more expensive cousins if all other things remain the same.
Annual operating expenses for FXZ are 0.62%, which makes it on par with most peer products in the space.
It has a 12-month trailing dividend yield of 1.62%.
Sector Exposure and Top Holdings
While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund&#39;s holdings is a valuable exercise. And, most ETFs are very transparent products that disclose their holdings on a daily basis.
For FXZ, it has heaviest allocation in the Materials sector --about 90.20% of the portfolio.
Looking at individual holdings, CF Industries Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cf#NYSE">CF</a>) accounts for about 4.75% of total assets, followed by FMC Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) and Albemarle Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alb#NYSE">ALB</a>).
FXZ&#39;s top 10 holdings account for about 42.04% of its total assets under management.
Performance and Risk
Year-to-date, the First Trust Materials AlphaDEX ETF has lost about -6.48% so far, and it&#39;s up approximately 2.79% over the last 12 months (as of 07/08/2024). FXZ has traded between $58.78 and $72.04 in this past 52-week period.
The fund has a beta of 1.20 and standard deviation of 24.45% for the trailing three-year period, which makes FXZ a medium risk choice in this particular space. With about 39 holdings, it has more concentrated exposure than peers.
Alternatives
First Trust Materials AlphaDEX ETF is a reasonable option for investors seeking to outperform the Materials ETFs segment of the market. However, there are other ETFs in the space which investors could consider.
Materials Select Sector SPDR ETF (ARCA:XLB) tracks Materials Select Sector Index and the FlexShares Morningstar Global Upstream Natural Resources ETF (ARCA:GUNR) tracks Morningstar Global Upstream Natural Resources Index. Materials Select Sector SPDR ETF has $5.42 billion in assets, FlexShares Morningstar Global Upstream Natural Resources ETF has $5.89 billion. XLB has an expense ratio of 0.09% and GUNR charges 0.46%.
Investors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the Materials ETFs.
<a href="https://www.zacks.com/stock/news/2297699/is-first-trust-materials-alphadex-etf-fxz-a-strong-etf-right-now?cid=CS-BENZ-FT-smart_beta_etf-2297699">To read this article on Zacks.com click here.</a>

ETFs

GUNR

Is First Trust Materials AlphaDEX ETF a Strong ETF Right Now?

UBS highlights 30 stocks poised for potential moves after the Fed's expected rate cut

Energy, Financials, and Materials stir up some interest on Wall Street

Dividend Champion, Contender, And Challenger Highlights: Week Of September 22

Wells Fargo analyst Richard Garchitorena maintained a Hold rating on FMC (FMC – Research Report) today and set a price target of $67.00. The compan...

Wells Fargo Reaffirms Their Hold Rating on FMC (FMC)

Analysts have been eager to weigh in on the Materials sector with new ratings on FMC (FMC – Research Report) and Piedmont Lithium (PLL – Research R...

Analysts Offer Insights on Materials Companies: FMC (FMC) and Piedmont Lithium (PLL)

FMC: The Market Is Overreacting To The Industry's Destocking

FMC announces distribution agreement with Ballagro Agro Tecnologia

Companies in the Materials sector have received a lot of coverage today as analysts weigh in on Lundin Mining (LUNMF – Research Report), Agnico Eag...

Analysts Offer Insights on Materials Companies: Lundin Mining (OtherLUNMF), Agnico Eagle (AEM) and FMC (FMC)

BofA's top 10 ideas for the fourth quarter

XLB: NEM, ALB, NUE among top S&P500 materials movers in Q3

ALLE

AMCR

AMLP

AUBN

AVGO

BANF

BBWI

BSVN

COFS

CSGS

CSWC

CTLT

CTRE

CTVA

CZFS

DLTR

EFSC

ENSG

EPRT

ETSY

FANG

FBNC

FCPT

FFMR

FITB

FMNB

FNCL

FSFG

GAIN

GATX

GILD

GNTY

GSBC

GWRS

HLAN

HOFT

IIPR

INVH

IROQ

ISTR

JKHY

KFRC

LANC

LAND

LDOS

LECO

LOGI

LUNMF

MDLZ

MPWR

MRNA

MSFT

MTCH

NDAQ

NXRT

OCSL

OFLX

OLED

PINE

PLOW

PNBI

POWI

QCOM

QNBC

QRVO

REXR

RSPM

SBAC

SBUX

SPOT

STAG

STLD

TFII

TOWN

TRNO

TROW

VCTR

VRSK

XRAY

YORW

Commodities

Contracts

Press Releases

FMC Corporation signs definitive agreement to sell Global Specialty Solutions business to Envu

FMC Corporation board elects John M. Raines to Board of Directors

Dividends

FMC Corporation Declares Quarterly Dividend

FMC Corporation announces second quarter earnings at higher end of guidance range; updates full-year outlook

Opinion

Rising Food Costs and Supply Chain Strains: How Agritech Companies Are Responding

FMC Corporation submits regulatory applications in eight countries for Dodhylex™ active

FMC Corporation granted a temporary restraining order against Sharda USA LLC for patent infringement in the United States

FMC Corporation announces dates for third quarter 2024 earnings release and webcast conference call

FMC Corporation and UN Global Compact Network USA convene global leaders to discuss future of sustainable food systems during United Nations General Assembly

FMC Corporation announces distribution agreement with Ballagro Agro Tecnologia Ltda. to expand biologicals crop protection offering in Brazil

BEVVF

CALM

CSE:BEE

CVGW

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

Comments

FMC

Intérêt court

FMC (NYSE:FMC) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL